Table 1.

Clinical characteristics of 197 patients with head and neck cancer. Numbers and percentages are given, n (%)

Characteristics	n (%)
Age, years, mean ± SD (min–max)	63 ± 11 (32–89)
Age, years
< 70   ≥ 70	137 (70)   60 (30)
Gender
Male  Female	144 (73)   53 (27)
Tumour site
Oropharynx  Oral cavity  Larynx  Other*	89 (45)   57 (29)   24 (12)   27 (14)
Tumour stage, UICC 8†
I-II  III-IV	121 (61)   76 (39)
Treatment
Surgery  Radiotherapy ± surgery‡  Radiotherapy + chemo- or other pharmacological treatment ± surgery ≠	24 (12) 104 (53)   69 (35)

^*Hypopharynx (n = 6), cancer of unknown primary (n = 6), salivary gland cancer (n = 5), nasal or sinus cancer (n = 5), nasopharynx (n = 3), and cancer involving the external auditory canal (n = 2). †Union for International Cancer Control 8th edition. ‡Seven patients received radiotherapy + brachytherapy, and 61/104 patients had surgery. ≠ Fifty-one patients received cisplatin, 1 patient received carboplatin, 17 patients received cetuximab, and 24/69 patients had surgery